RARE
Ultragenyx Pharmaceutical Inc. - Common Stock
NASDAQFinancial Statements
What does this mean?Income statement, balance sheet, and cash flow over time
| Metric | |
|---|---|
Institutional Ownership
What does this mean?Top institutions holding RARE
| Institution | Shares Held | Value | Date |
|---|---|---|---|
| Vanguard Group | 150,000,000 | $25,000,000,000 | Nov 2025 |
| BlackRock | 140,000,000 | $23,500,000,000 | Nov 2025 |
| State Street | 80,000,000 | $13,500,000,000 | Oct 2025 |
| Fidelity | 65,000,000 | $11,000,000,000 | Sep 2025 |
| Geode Capital | 35,000,000 | $5,900,000,000 | Nov 2025 |
ETF Holdings
What does this mean?Top ETFs holding RARE
| ETF | Weight | Shares |
|---|---|---|
| QQQ | 8.50% | 12,133,632 |
| VGT | 6.20% | 7,469,590 |
| SPY | 4.50% | 5,077,870 |
| IVV | 4.20% | 41,567,586 |
| VOO | 3.80% | 34,641,654 |
Frequently Asked Questions
Common questions about RARE
Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) is a publicly traded company listed on NASDAQ. Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) is included in the Stock Monitor database for research and watchlists.
The current stock price of RARE is $224.79, with a change of +3.79% in the latest session. Stock prices are updated during market hours and may be delayed.
Yes, RARE pays dividends with a current dividend yield of 3.79%. Dividend payments are typically made quarterly, though the exact schedule varies. Check the dividend calendar for upcoming ex-dividend dates.
The P/E (Price-to-Earnings) ratio of RARE is 27.79. This relatively high P/E may indicate growth expectations or that the stock is trading at a premium. The P/E ratio compares the stock price to earnings per share and is commonly used for valuation.
RARE has a market capitalization of $1.78 trillion, making it a mega-cap company. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.
The 52-week trading range for RARE is $186.35 (low) to $332.46 (high). This range represents the lowest and highest prices the stock has traded at over the past year.
Trade
Buy/Sell via broker links (affiliate).
Paper Trade
Save a buy/sell to your portfolio tracker (not a real trade).
Paper Orders
Limit/stop reminders, with optional bracket (take profit + stop loss).
Price Alerts
Notify when RARE crosses your target.
Company Info
What does this mean?About
Ultragenyx Pharmaceutical Inc. - Common Stock (RARE) is included in the Stock Monitor database for research and watchlists.